BIoEclipse Therapeutics Competitors and Similar CompaniesClear all
Zymeworks's competitors and similar companies include Coherus Oncology and ImmPACT-Bio.
 Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. |  Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. |  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | |
Founding Date | Founding Date 2003 | Founding Date 2010 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Vancouver, CA HQ Seattle, US | Locations Redwood City, US HQ Camarillo, US | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 45519% increase | Employees 14736% decrease | Employees 845% decrease |
Valuation ($) | Valuation ($) 973.3 m | Valuation ($) 85.6 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $106m (FY, 2025) | Revenue (est.) $42.2m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($81.1m) (FY, 2025) | Net income $168m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 125.9m | Total funding raised $ 174.5m | Total funding raised $ 18m |
For sources of this data, please see the company profile
View Company Profiles
Coherus Oncology
HQ
Redwood City, US
Employees
147↓ 36% decrease
Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
View companyImmPACT-Bio
HQ
Camarillo, US
Employees
84↓ 5% decrease
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company